Generation of feeder-independent transgene-free iPSC lines from a young-onset Parkinson’s disease (YOPD) patient with a homozygous PLA2G6: c.2222G>A (p. Arg741Gln) mutation (NCBSi003-A) and unaffected heterozygous parent (NCBSi004-A)

Church, 2005, The Personal Genome Project, Mol. Syst. Biol., 1, 10.1038/msb4100040 Gopurappilly, 2021, Pluripotent stem cell derived neurons as in vitro models for studying autosomal recessive Parkinson’s disease (ARPD): PLA2G6 and other gene loci, Exp. Med. Biol., 1347, 115, 10.1007/5584_2021_643 Konala, 2020, Derivation of three induced pluripotent stem cell lines under feeder-free culture conditions from peripheral blood mononuclear cells (PBMC) of Indian patients suffering from inherited retinal diseases carrying different mutations, Stem Cell Res., 45, 10.1016/j.scr.2020.101757 Okita, 2011, A more efficient method to generate integration-free human iPS cells, Nature Methods, 8, 409, 10.1038/nmeth.1591 Oliveira, 2021, Severe early-onset Parkinsonian syndrome caused by PLA2G6 heterozygous variants, Mov. Disord. Clin. Pract., 8, 794, 10.1002/mdc3.13230 Singh, 2021, Derivation of clinical-grade induced pluripotent stem cell lines from erythroid progenitor cells in xenofree conditions, Methods Mol. Biol., 2454, 775, 10.1007/7651_2021_349